We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Patient Experience Data Guidance Needs Labeling Details, Drugmakers Say
FDA Patient Experience Data Guidance Needs Labeling Details, Drugmakers Say
In comments on the first of four FDA patient experience data guidances, Allergan and Roche urged the agency to add more details on data that can be used in labeling.